Qiqiang Guo

Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.

Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.

Journal: BMJ medicine
Published: June 06, 2026

GLP-1 Receptor Agonists and Noncardiometabolic Outcomes: An Umbrella Review of Meta-Analyses.

GLP-1 Receptor Agonists and Noncardiometabolic Outcomes: An Umbrella Review of Meta-Analyses.

Journal: JAMA network open
Published: March 31, 2026

Corrigendum to "LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells" [Cancer Lett. 317 (2012) 24-32].

Corrigendum to "LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells" [Cancer Lett. 317 (2012) 24-32].

Journal: Cancer letters
Published: January 13, 2026

Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes.

Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 29, 2025

Global Burden of Early-Onset Cancers Attributable to Metabolic Risk Factors from 1990 to 2021 and Projections to 2040.

Global Burden of Early-Onset Cancers Attributable to Metabolic Risk Factors from 1990 to 2021 and Projections to 2040.

Journal: Endocrinology and metabolism (Seoul, Korea)
Published: July 24, 2025

The deacetylase SIRT6 reduces amyloid pathology and supports cognition in mice by reducing the stability of APP in neurons.

The deacetylase SIRT6 reduces amyloid pathology and supports cognition in mice by reducing the stability of APP in neurons.

Journal: Science signaling
Published: December 10, 2024

ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment.

ROS-ATM-CHK2 axis stabilizes HIF-1α and promotes tumor angiogenesis in hypoxic microenvironment.

Journal: Oncogene
Published: October 25, 2024

The deubiquitination-PARylation positive feedback loop of the USP10-PARP1 axis promotes DNA damage repair and affects therapeutic efficacy of PARP1 inhibitor.

The deubiquitination-PARylation positive feedback loop of the USP10-PARP1 axis promotes DNA damage repair and affects therapeutic efficacy of PARP1 inhibitor.

Journal: Oncogene
Published: August 17, 2024

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research.

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research.

Journal: Cancer biology & medicine
Published: June 28, 2024

Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response.

Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response.

Journal: Cell reports
Published: May 15, 2024

The phosphorylation-deubiquitination positive feedback loop of the CHK2-USP7 axis stabilizes p53 under oxidative stress.

The phosphorylation-deubiquitination positive feedback loop of the CHK2-USP7 axis stabilizes p53 under oxidative stress.

Journal: Cell reports
Published: December 12, 2023

A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization.

A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization.

Journal: Redox biology
Published: October 19, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026